GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 11, 2024
Displaying entries 22051 - 22100 of 40384 in total
PDB ID ▼ UniProt ID Title Descriptor
6D6U P18507 Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A
6D6U 6D6U Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A
6D6T P47870 Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation B
6D6T P14867 Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation B
6D6T 6D6T Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation B
6D6F P00698 Triclinic lysozyme cryocooled to 100 K with 47% xylose as cryoprotectant
6D67 P0AEX9 Crystal structure of the human dual specificity phosphatase 1 catalytic domain (C258S) as a maltose binding protein fusion (maltose bound form) in complex with the designed AR protein mbp3_16
6D67 P28562 Crystal structure of the human dual specificity phosphatase 1 catalytic domain (C258S) as a maltose binding protein fusion (maltose bound form) in complex with the designed AR protein mbp3_16
6D67 6D67 Crystal structure of the human dual specificity phosphatase 1 catalytic domain (C258S) as a maltose binding protein fusion (maltose bound form) in complex with the designed AR protein mbp3_16
6D64 P29016 Crystal Structure of Human CD1b in Complex with POPC
6D64 P61769 Crystal Structure of Human CD1b in Complex with POPC
6D5R P00800 Hexagonal thermolysin cryocooled to 100 K with 50% xylose as cryoprotectant
6D5Q P00800 Hexagonal thermolysin cryocooled to 100 K with 30% xylose as cryoprotectant
6D5P P00800 Hexagonal thermolysin cryocooled to 100 K with 20% xylose as cryoprotectant
6D5N P00800 Hexagonal thermolysin (295) in the presence of 50% xylose
6D5D 6D5D Structure of Caldicellulosiruptor danielii GH48 module of glycoside hydrolase WP_045175321
6D58 P01860 Crystal structure of a Fc fragment of Human IgG3
6D50 A0A078SUX9 Bacteroides uniforms beta-glucuronidase 2 bound to D-glucaro-1,5-lactone
6D4N 6D4N Crystal structure of a Fc fragment of Rhesus macaque (Macaca mulatta) IgG4
6D4M 6D4M Crystal Structure of a Fc Fragment of Rhesus macaque (Macaca mulatta) IgG3
6D4I F7H602 Crystal Structure of a Fc Fragment of Rhesus macaque (Macaca mulatta) IgG2
6D4E F6RL33 Crystal Structure of a Fc Fragment of Rhesus macaque (Macaca mulatta) IgG1.
6D41 A0A174CQK8 Bacteriodes uniformis beta-glucuronidase 1 bound to D-glucaro-1,5-lactone
6D3U A0A084JZF2 Complex structure of Ulvan lyase from Nonlaben Ulvanivorans- NLR48
6D3B P03472 INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) APO FORM
6D24 Q1WBU6 Trypanosoma cruzi Glucose-6-P Dehydrogenase in complex with G6P
6D1W Q13563 human PKD2 F604P mutant
6D1U P0AEY0 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin
6D1U Q16602 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin
6D1U O60894 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin
6D1U 6D1U Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin
6D0U Q91MA7 Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit
6D0U 6D0U Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit
6D0N C9CPP6 Crystal structure of a CLC-type fluoride/proton antiporter, V319G mutant
6D0N 6D0N Crystal structure of a CLC-type fluoride/proton antiporter, V319G mutant
6D0K C9CPP6 Crystal structure of a CLC-type fluoride/proton antiporter, E118Q mutant
6D0K 6D0K Crystal structure of a CLC-type fluoride/proton antiporter, E118Q mutant
6D0J C9CPP6 Crystal structure of a CLC-type fluoride/proton antiporter
6D0J 6D0J Crystal structure of a CLC-type fluoride/proton antiporter
6D05 P02786 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 2.
6D05 P02787 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 2.
6D05 A5K736 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 2.
6D04 P02786 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 1.
6D04 P02787 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 1.
6D04 A5K736 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 1.
6D03 P02786 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; one molecule of parasite ligand.
6D03 P02787 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; one molecule of parasite ligand.
6D03 A5K736 Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; one molecule of parasite ligand.
6CZS P09668 Crystal structure of human pro-cathepsin H C26S mutant
6CZK P09668 Crystal structure of wild-type human pro-cathepsin H

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024